Market
Will a follow-up study confirm 90% effectiveness of the malaria vaccine by mid-2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Peer-reviewed journals or official announcements from Seattle Children's or University of Washington
Story
Single-Dose Malaria Vaccine Achieves 90% Protection in New Study Published in Nature Medicine by Seattle Children's and University of Washington
Jan 3, 2025, 03:16 PM
A recent study published in 'Nature Medicine' has revealed a breakthrough in malaria vaccination, demonstrating that a single-dose immunization using a genetically weakened whole malaria parasite vaccine can provide 90% protection against the disease. This development is part of ongoing research efforts to combat malaria, with the study being led by scientists from Seattle Children's and the University of Washington. Additionally, NIH researchers have identified a novel class of antibodies that targets a previously untapped portion of the malaria parasite, which could pave the way for new prevention strategies. These findings highlight significant advancements in malaria vaccine research and potential new avenues for treatment.
View original story
Similar markets
Efficacy above 90% • 25%
Efficacy between 75% and 90% • 25%
Efficacy between 50% and 75% • 25%
Efficacy below 50% • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Antimalarial drugs • 25%
Indoor residual spraying • 25%
Vaccine deployment • 25%
Insecticide-treated nets • 25%
Yes • 50%
No • 50%
